Acquisition enables WuXi AppTec to offer its customers end-to-end support in the creation and development of cutting-edge cell and gene therapies for patients in need worldwide
A recent review study suggests that the development of certain antivirals and gene therapy are likely to progress quickest in the fight against dangerous coronviruses such as SARS-CoV-2